Start Shopping

FDA Approves First Automated Insulin Delivery Device for Type 1 Diabetes

FDA Approves First Automated Insulin Delivery Device for Type 1 Diabetes

On September 28, 2016 the U.S Food and Drug Administration announced that it had approved the first automated insulin delivery device for type 1 diabetes.  The Medtronic MiniMed® 670G is a hybrid closed loop system. As such, it is the first FDA-approved device that is intended to automatically monitor blood glucose levels and provide appropriate basal insulin doses in people 14 years of age and older with type 1 diabetes.

This product has been in development for many years and industry veterans know that Medtronic often referred to it as the "artificial pancreas" since its purpose is to duplicate the work of the pancreas. The device measures the patient's blood glucose level every five minutes and then either dispenses or withholds insulin accordingly. The patient is then freed from the task of constantly or frequently measuring their blood glucose levels and then taking corrective action on their own.

Up until the approval of this device, continuous glucose monitoring (CGM) and insulin infusion pumps were separate devices that required human interface between the two. With the 670G the work of two devices is now performed seamlessly in a single device. This is a significant step forward for the technology and for diabetic patients who are otherwise unable to manage their blood sugar levels.

As you know, DDP Medical Supply has an excellent relationship with Medtronic and we will be ready to assist you and your patients in meeting physician orders for this new device. You can rest assured that our team will receive the appropriate training on the new device and when you call with questions we will either have the answers or know where to get them quickly.

As of October 20, 2016 Medtronic has not yet posted any information on their web site regarding the availability of the new device. As always, as soon as we know more we will let you know.

See the FDA Press Release here: